InvestorsHub Logo

entdoc

06/10/13 11:45 AM

#126941 RE: entdoc #126936

the thing that bugs me the most about biotech: Cotara, for example. IMO a perfectly logical approach to solid tumors.
Attack at the center; THEN attack at the periphery too (with Bavi). Who out there knows why the technology isn't being pursued? Somebody does. Why don't we? Surely the results are whispered about. Why aren't failed results of major corporate projects made public? Why no word(at all!) out of China in
the past decade of results there with Cotara and lung cancer? Someone knows those results. Clearly there are transparency stockholder/corporate disclosure issues not covered by the FTC. What did "they" know and when did they know it? And why can't we know it at some reasonable/similar juncture?